As of 2026, the AI cancer diagnostics market is valued at approximately $1.28 billion, and it is expected to double by 2035 (Towards Healthcare, 2026).
The concept has been used in manufacturing and industry to create virtual copies of machinery for testing quality control, optimization, and potential failures.